Executive Series 12 Dec 19: Clinuvel Pharmaceuticals Limited (CUV) CEO & MD, Dr Philippe Wolgen

Clinuvel Pharmaceuticals Limited (CUV) CEO & MD Dr Philippe Wolgen speaks with Tom Piotrowski about the recent volatility of company’s share price, its self-distribution model in US and the global uniform price policy.

Visit CommSec’s Executive Series website:

Visit CommSec’s Market News hub:


Follow us on Twitter:


Subscribe to CommSecTV:

CommSec,Online Share Trading,Online Broking,Market Update,Online Trading,Market Insights,ASX,Australian Shares,Investing,stocks,Executive Series,Tom Piotrowski,Clinuvel Pharmaceuticals,Dr Philippe Wolgen,CUV,Clinuvel,